Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Auscrete Corp. (OTC: ASCK) is “One to Watch”

Construction spending in U.S. is projected to exceed $1.42 trillion in 2021 Homeownership rate in the U.S. continues to decline while median price of new homes sold rose to $384,900 Lack of affordable housing is termed a “crisis” in communities nationwide The company’s energy efficient, lightweight concrete technology is a cost-effective, structurally superior design created […]

Pacific Software, Inc. (PFSF) is “One to Watch”

Designing and powering Hyperledger blockchain technologies Creating solutions for sectors highly reliant on supply chain transparency and efficiency Business model allows for the creation of several wholly owned subsidiaries Working relationship with IBM provides expertise on supply chain implementations Management has more than 50 years of combined experience in finance, M&A, investments and more Advisory […]

World Crypto Con Unveils University Research Showcase Scholarship

World Crypto Con to award six university teams with opportunity to present blockchain research and projects Online applications accepted until August 31, with winners being revealed on October 1 Conference to feature over 5,000 attendees and more than 150 exhibitors World Crypto Con (“WCC”), the cryptocurrency and blockchain industry’s most immersive and interactive conference experience, […]

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Applicable to Multiple Industries

Active investigation phase in the EU, Canada, China, Japan and India Forming four new wholly owned subsidiaries Seeks to acquire an equitable tax treatment Cannabinoids are poorly absorbed by the body’s gastrointestinal tract, a trait that Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) lipophilic enhancement technology DehydraTECH™ is changing. Previously, consumers have turned to cannabis […]

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) Focused on Gold Exploration Project amid Dwindling Global Supply

Core drilling program completed at San Roque property in Argentina Up to 600 core samples are being shipped to a certified laboratory for assay, with management optimistic about “favorable results” Company also pursuing cobalt and lithium, two other minerals risking global shortage due to increased demand Reputable mining experts have issued stern warnings in recent […]

GreenBox POS, LLC (GRBX) Blockchain Solutions Advance Progression to a Cashless Society

Electronic payments engendering transition to a cashless society Electronic payments carry high transaction costs Blockchain technology holds the promise of lowering those costs Latest payment system, QuickCard, launched and running successfully If cash is still king, it has to be a constitutional monarchy, for electronic payment instruments and technologies like those being developed by GreenBox […]

EVIO Inc. (EVIO) to Exhibit at Top Cannabis Industry Expo

Over 7,500 people expected to attend Cannabis Business Summit & Expo More than 85 percent of attendees to have decision-making or purchasing authority EVIO Colorado licensee gets ISO approval for pesticide testing Cannabis testing market to hit $1.4 billion by 2021 EVIO Inc. (OTCQB: EVIO), an accredited and established leader in cannabis testing, is set […]

 

From Our Blog

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes

March 31, 2026

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100. The LB-100 compound is a proprietary small-molecule PP2A inhibitor that is designed to target protein phosphatase 2A (“PP2A”), introducing a potential new treatment paradigm aimed at enhancing existing […]

Rotate your device 90° to view site.